Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.7926 | 1 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0036 | 0.3227 | 0.4072 |
Loa Loa (eye worm) | RNA binding protein | 0.0061 | 0.7926 | 0.8579 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0018 | 0 | 0.5 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0058 | 0.7277 | 0.9182 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0035 | 0.3048 | 0.3845 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.3227 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.3227 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0018 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.7926 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.3481 | 0.3768 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.3227 | 0.4072 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0061 | 0.7926 | 0.7926 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0018 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0036 | 0.3227 | 0.3227 |
Brugia malayi | TAR-binding protein | 0.0061 | 0.7926 | 0.7926 |
Echinococcus multilocularis | tar DNA binding protein | 0.0061 | 0.7926 | 1 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.7926 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0061 | 0.7926 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | bromodomain containing protein | 0.0061 | 0.7915 | 0.9985 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0018 | 0 | 0.5 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0022 | 0.0665 | 0.0839 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0018 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.3227 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | zinc finger protein | 0.0019 | 0.0137 | 0.0173 |
Echinococcus granulosus | zinc finger protein | 0.0019 | 0.0137 | 0.0173 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0061 | 0.7926 | 0.8579 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0022 | 0.0665 | 0.0839 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0058 | 0.7277 | 0.9182 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.9239 | 1 |
Schistosoma mansoni | hypothetical protein | 0.002 | 0.0325 | 0.041 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0018 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.3903 | 0.4224 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.7926 | 1 |
Loa Loa (eye worm) | TAR-binding protein | 0.0061 | 0.7926 | 0.8579 |
Loa Loa (eye worm) | PHD-finger family protein | 0.002 | 0.0325 | 0.0352 |
Brugia malayi | PHD-finger family protein | 0.0024 | 0.1086 | 0.1086 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0018 | 0 | 0.5 |
Brugia malayi | RNA binding protein | 0.0061 | 0.7926 | 0.7926 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.4243 | 0.4592 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0022 | 0.0665 | 0.0839 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.7926 | 1 |
Schistosoma mansoni | zinc finger protein | 0.0019 | 0.0137 | 0.0173 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0035 | 0.3048 | 0.3845 |
Entamoeba histolytica | hypothetical protein | 0.0036 | 0.3227 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0037 | 0.3469 | 0.3469 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0036 | 0.3227 | 0.4072 |
Toxoplasma gondii | exonuclease III APE | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0036 | 0.3227 | 0.4072 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0018 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 1.967 uM | In vitro Inhibition on growth of human MCF 7 breast carcinoma cell line | ChEMBL. | 15801828 |
IC50 (functional) | = 1.967 uM | In vitro Inhibition on growth of human MCF 7 breast carcinoma cell line | ChEMBL. | 15801828 |
IC50 (functional) | = 6.99 uM | In vitro Inhibition on growth of human MiaPaCa-2 pancreatic carcinoma cell line | ChEMBL. | 15801828 |
IC50 (functional) | = 6.99 uM | In vitro Inhibition on growth of human MiaPaCa-2 pancreatic carcinoma cell line | ChEMBL. | 15801828 |
IC50 (functional) | = 12.9 uM | In vitro Inhibition on growth of human HeLa cervical carcinoma cell line | ChEMBL. | 15801828 |
IC50 (functional) | = 12.9 uM | In vitro Inhibition on growth of human HeLa cervical carcinoma cell line | ChEMBL. | 15801828 |
IC50 (functional) | = 15.3 uM | In vitro Inhibition on growth of human Hep 2 laryngeal carcinoma cell line | ChEMBL. | 15801828 |
IC50 (functional) | = 27.8 uM | In vitro Inhibition on growth of human SW 620 colon carcinoma cell line | ChEMBL. | 15801828 |
IC50 (functional) | = 27.8 uM | In vitro Inhibition on growth of human SW 620 colon carcinoma cell line | ChEMBL. | 15801828 |
IC50 (functional) | = 36.4 uM | In vitro Inhibition on growth of human WI 38 diploid fibroblast cell line | ChEMBL. | 15801828 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 15801828 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.